Novel Genomic Testing: Improving Diagnostic Confidence for Lung Nodule & ILD Diagnosis

Dr. Kurman will discuss the transformative role novel genomic tests play in guiding patient management when bronchoscopy is inconclusive and how UIP evidence is used for a more confident ILD diagnosis and prognosis.  He will present cases from his clinical practice, outline his method for incorporating genomic testing into his patient work-up and provide an overview of the Percepta Genomic Sequencing Classifier for stratifying risk of lung cancer when bronchoscopy is inconclusive and Envisia Genomic Classifier for early accurate diagnosis in patients with diverse Interstitial Lung Diseases (ILD).